Inventor · disambiguated record
Binghui Shen
Also filed as: SHEN BINGHUI
7 granted patents·2 pending applications·15 citations·filing 2006–2022
80Inventor score
Top patents by PatentIndex Score
9 records- 0192US9932310B2DNA2 inhibitors for cancer treatmentHOPE CITY·Filed 2017·Granted Apr 3, 2018·5 cites·13 claims
- 0290US10173984B2DNA2 inhibitors for cancer treatmentHOPE CITY·Filed 2018·Granted Jan 8, 2019·5 cites·8 claims
- 0389US11198675B2DNA2 inhibitors for cancer treatmentHOPE CITY·Filed 2020·Granted Dec 14, 2021·2 cites·3 claims
- 0489US10562856B2DNA2 inhibitors for cancer treatmentHOPE CITY·Filed 2018·Granted Feb 18, 2020·3 cites·8 claims
- 0575US11780815B2DNA2 inhibitors for cancer treatmentHOPE CITY·Filed 2021·Granted Oct 10, 2023·0 cites·14 claims
- 0662US2023175072A13 flap okazaki fragments and uses thereofHOPE CITY·Filed 2022·Application pending·0 cites
- 0756US11672812B2Methods and compositions comprising tyrosine kinase inhibitor and triptolide for the treatment of cancerHOPE CITY·Filed 2021·Granted Jun 13, 2023·0 cites·9 claims
- 0846US7927790B2Suppression of HIV-1 replication via inhibition of human flap endonuclease-1-mediated HIV-1 central DNA flap processingHOPE CITY·Filed 2006·Granted Apr 19, 2011·0 cites·15 claims
- 0933US2021317217A1Humanized anti-vegfr2 single-chain antibody and use thereofZHEJIANG BLUE SHIELD PHARMACEUTICAL CO LTD·Filed 2019·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →